Picture of Sangrix logo

SGRX — Sangrix Balance Sheet

0.000.00%
us flag iconLast trade - 00:00
Consumer DefensivesHighly SpeculativeMicro CapValue Trap

Annual balance sheet for Sangrix, fiscal year end - June 30th, USD millions except per share, conversion factor applied.

2022
June 30th
2023
June 30th
2024
June 30th
2025
June 30th
2026
June 30th
Period Length:12 M12 M12 M12 M12 M
Source:20-F20-F20-F20-F20-F
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments1.170.6771.410.0561.57
Net Total Receivables4.420.4685.082.933.17
Prepaid Expenses
Total Other Current Assets
Total Current Assets5.753.576.683.5410.2
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment8.037.370——
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets3513.36.683.5421.2
Accounts Payable
Payable / Accrued
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities0.32.592.490.3721.46
Long Term Debt
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities0.33.075.02-0.36411.3
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity34.710.31.663.99.82
Total Liabilities & Shareholders' Equity3513.36.683.5421.2
Total Common Shares Outstanding